NASDAQ:JAZZ - IE00B4Q5ZN47 - Common Stock
JAZZ gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 193 industry peers in the Pharmaceuticals industry. While JAZZ is still in line with the averages on profitability rating, there are concerns on its financial health. JAZZ scores decently on growth, while it is valued quite cheap. This could make an interesting combination.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -3.7% | ||
ROE | -10.92% | ||
ROIC | 5.47% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 15.03% | ||
PM (TTM) | N/A | ||
GM | 88.71% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 1.17 | ||
Debt/FCF | 4.33 | ||
Altman-Z | 1.34 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.62 | ||
Quick Ratio | 1.37 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 18.54 | ||
Fwd PE | 5.59 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 6.02 | ||
EV/EBITDA | 8.3 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
123.11
+2.58 (+2.14%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 18.54 | ||
Fwd PE | 5.59 | ||
P/S | 1.83 | ||
P/FCF | 6.02 | ||
P/OCF | 5.67 | ||
P/B | 2.01 | ||
P/tB | N/A | ||
EV/EBITDA | 8.3 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -3.7% | ||
ROE | -10.92% | ||
ROCE | 6.92% | ||
ROIC | 5.47% | ||
ROICexc | 6.73% | ||
ROICexgc | 82.21% | ||
OM | 15.03% | ||
PM (TTM) | N/A | ||
GM | 88.71% | ||
FCFM | 30.34% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 1.17 | ||
Debt/FCF | 4.33 | ||
Debt/EBITDA | 3.37 | ||
Cap/Depr | 11.29% | ||
Cap/Sales | 1.86% | ||
Interest Coverage | 250 | ||
Cash Conversion | 102.28% | ||
Profit Quality | N/A | ||
Current Ratio | 1.62 | ||
Quick Ratio | 1.37 | ||
Altman-Z | 1.34 |